• SENSEX 74,294.96
    -19.63 (--0.03%)
  • BANKNIFTY 56,358.70
    302.95 (+0.54%)
  • HDFC Bank
    733.50 1,020.35(%)
  • ITC
    262.20 256.25(%)
  • The Bombay Burmah
    1,531.60 2,135.00(%)
  • Rentomojo
    492.20 480.00(%)
  • Glass Wall Syst.
    304.50 304.50(%)
  • Multi Comm. Exc.
    3,232.00 1,545.65(%)
  • UltraTech Cem.
    10,670.00 10,329.00(%)
  • Adani Total Gas
    674.80 859.70(%)
  • EIH
    320.50 414.90(%)
  • Bajaj Finance
    1,036.10 1,177.60(%)
  • Lords Mark Industries
    89.68 669.70(%)
  • Meesho
    219.80 254.65(%)
  • Syrma SGS Tech.
    1,764.95 1,764.95(%)
  • Aditya Birla Cap
    404.25 430.55(%)
  • Raksan Transformers
    286.65 286.65(%)
  • Atul
    6,195.10 7,198.20(%)
  • Karamtara Engg.
    378.20 378.20(%)
  • TCS
    2,101.00 1,976.00(%)
  • Billionbrains
    195.50 227.00(%)
  • Tata Chemicals
    688.00 581.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vineet Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71715.0
  • ISIN : INE505Y01010
36.78 1 (2.25%)
  • As on 20 Sep 2026 (EOD)

  • Today’s Low

    35.41

  • Today’s High

    37.37

  • Open

    36.90

  • Perv Close

    35.97

  • 52W Low

    27.96

  • 52W High

    43.50

Key Indicators

  • P/E(TTM)

    62.84

  • Mar.Cap (₹Cr.)

    70.64

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.75

  • Debt-Equity Ratio

    2.25

  • AGM Date

    18-Sep-2026

  • EPS

    0.58

  • P/E Ratio

    62.84

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    70.64

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    19.21

  • BV (₹)

    23.70

  • Sales( ₹ in Cr.)

    59.40

  • NP (in Cr.)

    1.11

  • NP Var(%)

    105.0

  • Div%

    0.0

  • CPS (₹)

    1.80

  • EPS (₹)

    0.60

  • Traded Value (₹ in Lakhs)

    70.01

  • 52 Week High

    43.50

  • 52 Week Low

    27.96

  • Price BSE

    36.0

  • Price NSE

    37.00

  • Market Capital( in Cr.)

    70.01

  • P/C Ratio

    19.60

  • P/E Ratio

    62.20

  • Price Vs.BV

    0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 75.00 150.59 212.29 191.17 243.48 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 75.00 150.59 212.29 191.17 243.48 0.00
Other Income 1.99 0.46 0.12 0.29 0.39 0.00
Stock Adjustments -6.47 17.79 -4.23 5.85 -5.36 0.00
Total Income 70.52 168.84 208.18 197.31 238.51 0.00
EXPENDITURE :            
Raw Materials 63.77 131.70 168.10 151.40 192.76 0.00
Power and Fuel Cost 3.99 6.30 6.15 4.74 7.03 0.00
Employee Cost 5.34 6.38 6.00 4.91 5.57 0.00
Other Manufacturing Expenses 8.23 11.63 13.40 16.94 21.20 0.00
Selling and Administration Expenses 3.41 5.10 5.58 5.09 2.42 0.01
Miscellaneous Expenses 0.07 0.07 1.18 0.79 1.00 0.00
Employee Benefit Expenses 5.34 6.38 6.00 4.91 5.57 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 84.81 161.17 200.41 183.86 229.98 0.01
Operating Profit -14.29 7.66 7.78 13.45 8.54 -0.01
Interest 3.98 4.78 3.38 2.09 2.67 0.00
Gross Profit -18.27 2.88 4.40 11.36 5.87 -0.01
Depreciation 2.50 2.52 2.37 2.02 1.81 0.00
Profit Before Tax -20.77 0.36 2.03 9.34 4.06 -0.01
Current Tax 0.00 -0.06 0.56 3.18 1.28 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.58 -0.60 0.22 -0.48 1.00 0.00
Reported Net Profit -20.19 1.03 1.25 6.64 1.78 -0.01
Extraordinary Items 1.90 0.24 0.00 0.00 0.00 0.00
Adjusted Net Profit -22.09 0.79 1.25 6.64 1.78 -0.01
Adjustment below Net Profit 0.00 0.00 0.00 -0.04 0.22 0.00
P & L Balance brought forward 14.27 13.24 12.91 6.31 4.31 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.92 0.00 0.00 0.00
P & L Balance carried down -5.92 14.27 13.24 12.91 6.31 -0.01
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 10.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 1.00 0.00 0.00
Earnings Per Share-Unit Curr -21.90 1.11 1.36 7.20 1.93 -0.27
Earnings Per Share(Adj)-Unit Curr -18.40 0.93 1.14 6.05 - -
Book Value 15.89 37.67 36.54 36.03 28.87 9.73
Book Value(Adj)-Unit Curr 13.35 31.66 30.70 30.28 - -

Shareholding Pattern

  • Promoter Group

    5.98%

  • Public Share Holding

    94.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,149,097 5.98 1,149,097 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,149,097 5.98 1,149,097 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 95,609 0.50 95,609 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 95,609 0.50 95,609 1
2] Non Institution
Bodies Corporate 288,400 1.50 288,400 30
Clearing Members 0 0.00 0 0
Directors of their Relatives 50,254 0.26 50,254 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 275,824 1.44 275,824 86
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 318,073 1.66 318,073 180
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,761,846 61.24 11,761,846 122
Individuals holding nominal share capital up to Rs. 1 lakh 5,173,199 26.94 5,173,199 9,464
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17,961,560 93.52 17,961,560 9,886
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 19,206,266 100.00 19,206,266 9,901

Company Background

Vineet Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vineet Laboratories Ltd
  • BSE Code : 71715.0
  • ISIN : INE505Y01010

  • Incorporation Year

    2016

  • Registered Office

    SyNo 11/A3 Saheb Nagar KurduVi
    Chintal Kunta Eshwaramma LB Nr, Hyderabad,
    Telangana-500074

  • Telephone

    91-40-24128833

  • FAX

  • Chairman

    Dilip V Acharekar

  • Managing Director

  • Company Secretary

    Ramesh Kumar Bandari

  • Auditor

    NSVR & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Vineet Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vineet Laborator 36.45 76.98 75.00 62.84 0.00
Abbott India 27,273.30 7,217.19 6,929.05 35.89 43.78
Astrazeneca Phar 6,751.40 2,304.07 2,275.58 99.50 27.86
Glaxosmi. Pharma 2,851.85 3,932.76 3,790.20 45.56 58.17
Novartis India 2,057.50 393.10 354.33 51.96 15.94
Cipla 1,371.45 20,102.60 18,979.95 36.04 13.88
Bliss GVS Pharma 680.40 773.53 729.81 63.23 12.51
Amrutanjan Healt 493.65 520.13 502.55 26.44 24.16
Fermenta Biotec. 475.75 474.15 450.25 22.21 18.77
Guj. Themis Bio. 427.65 168.25 165.82 114.34 18.05
Ambalal Sarabhai 40.45 19.52 3.94 74.91 6.77